Balbino, B., Herviou, P., Godon, O., Stackowicz, J., Goff, O. R., Iannascoli, B., . . . Reber, L. L. (2020). The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. J Clin Invest.
Chicago ZitierstilBalbino, Bianca, et al. "The Anti-IgE MAb Omalizumab Induces Adverse Reactions By Engaging Fcγ Receptors." J Clin Invest 2020.
MLA ZitierstilBalbino, Bianca, et al. "The Anti-IgE MAb Omalizumab Induces Adverse Reactions By Engaging Fcγ Receptors." J Clin Invest 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.